---
layout: post
title: "Cancer Treatment Monitoring with EFIRM"
author: "EZLife Bio"

---

MDPI cancers has recently published an exciting paper regarding liquid biopsy and its potential applications in therapeutic treatment monitoring. A cohort of 22 lung cancer subjects with samples taken periodically over a period of 61 to 272 days was evaluated with EFIRM,  NGS, and ddPCR. 

This publication was a project including authors from EZLife Bio, the National Cancer Institute, and UCLA. Read more about it below!

<a href="https://www.mdpi.com/2072-6694/13/13/3342"> Link on the Cancers Website </a>
